HOME >> MEDICINE >> NEWS
Kidney disease in diabetics relates to insulins effectiveness, say Pittsburgh researchers

PITTSBURGH, Sept. 1 Insulin resistance, a condition commonly associated with the development of type 2 diabetes, is likely a major cause of kidney disease, or nephropathy, in people with type 1 diabetes, according to study results published by University of Pittsburgh Graduate School of Public Health (GSPH) researchers in the September issue of Kidney International, a journal of the International Society of Nephrology.

"Kidney disease is a major lethal complication for people with diabetes, particularly those with type 1 diabetes, and until now there has been no clear explanation for its cause beyond blood sugar itself," said principal investigator Trevor Orchard, M.D., professor and acting chair, department of epidemiology, GSPH. "We now suspect that reducing or preventing insulin resistance, possibly through exercise, weight loss and drugs, may help people with type 1 diabetes avoid nephropathy."

The study analyzed data from the Pittsburgh Epidemiology of Diabetes Complication Study (PEDCS), a 10-year prospective investigation based on a cohort of adults with type 1, or childhood-onset, diabetes. Of the 658 subjects in PEDCS, 485 did not have nephropathy at baseline and were followed for the current study.

Fifty-six of the 485 subjects developed nephropathy during either the first five years of follow-up, or during years 6-10. Researchers found that in all cases, strong relationships existed between nephropathy and insulin resistance throughout follow up, unlike other risk factors such as blood pressure and blood fats, which only predicted nephropathy in the short term.

To measure insulin resistance, investigators used a novel calculation based on waist-to-hip ratio, hypertension status and long-term blood sugar levels.

"Although our measure of insulin resistance is an estimate based on easier-to-measure factors, it is strongly correlated with the gold standard euglycemic clamp studies and clearly stands out as the leading p
'"/>

Contact: Kathryn Duda
412-624-2607
University of Pittsburgh Medical Center
1-Sep-2002


Page: 1 2

Related medicine news :

1. Kidney cancer surgery safer at high-volume hospitals
2. Kidney transplant patients who develop diabetes show poor short-term outcomes
3. Kidney transplant proposal reduces wait from 24 to 14 months, improves equity for blacks & women
4. Kidney Transplants From Living Donors Reduce Long-Term Costs Of Care
5. The Break Even Cost Of Kidney Transplants Is Shrinking
6. Kidney Transplant Recipients Require Less Long-Term Care If They Receive Well-Matched Donor Organs
7. New Strategy May Succeed At Extending The Life Of Transplanted Kidneys
8. Immunex Advances CD40 Ligand To Phase II Clinical Trial In People With Metastatic Kidney Cancer
9. Maternal Tissue Typing Could Improve Selection Of Kidney Transplant Donors
10. Researchers Begin Drug Trial In Hope Of Finding New Ways To Treat Acute Kidney Failure
11. Organ Rejection Drug Also Shows Promise For The Treatment Of Kidney Disease

Post Your Comments:
(Date:3/31/2015)... Tampa, FL (PRWEB) March 31, 2015 ... of America, has met all criteria for Laboratory Accreditation ... is given only to laboratories that apply rigid standards ... the performance of proficiency testing, and pass a rigorous ... earned COLA accreditation as a result of a long-term ...
(Date:3/31/2015)... Los Angeles, CA (PRWEB) March 31, 2015 ... titled “Would You Go Down the Silicone Slope?” provides a ... , dermal filler , and laser treatments . ... an example) and reality TV stars such as Kim Kardashian ... and other social media are increasingly seen as significant influences ...
(Date:3/31/2015)... March 31, 2015 Dr. St. Ledger recently ... for Advanced Dental Education. Here, he participated in the ... to create a greater predictability in cases of severely worn ... of tooth wear, and the correlation to GERD and Sleep ... Mentor at Spear Education. After the workshop he attended, ...
(Date:3/31/2015)... March 31, 2015 Dr. Uzma Parvez is ... 19th, Dr. Parvez conducted Grand Grounds Presentations at St. Michael’s ... and Managing Side Effects”. The event was attended by ... She received very positive feedback from the Grand Rounds. ... that they’ve had in a while. , Ahead, Dr. ...
(Date:3/31/2015)... 31, 2015 Former 49ers linebacker Chris Borland ... his first year of a promising NFL career. In a ... Earth Senior Writer Will Leitch explores the curious case ... talks about the decision making process that Borland and other ... health over a large paycheck, and what impact, if any, ...
Breaking Medicine News(10 mins):Health News:Local Medical DNA Labs, LLC. Recognized for Quality Laboratory Services 2Health News:Cosmetic Surgery: Does Social Media Pressure Young Girls to Get Botox and Fillers? 2Health News:The dentists at Upper Montclair Dental Associates are happy to announce exciting new happenings at their practice. 2Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3
(Date:3/31/2015)... DALLAS , March 31, 2015 ... H1 2015" therapeutic market research report of 68 ... its online business intelligence library. The ... information on the therapeutic development for Pemphigus ... therapeutics assessment by drug target, mechanism of action ...
(Date:3/31/2015)... MALVERN, Pa. , March 31, 2015  SCILEX ... commercialization of products focused on the treatment of pain, ... Tokyo Japan ), a member of ITOCHU ... one of the three leading sogo shosha (general trading ... a strategic investment in SCILEX.  ICF has worked closely ...
(Date:3/31/2015)... 31, 2015 Medela has announced the ... Invia ® Motion™-Endure personal pumps to its Negative ... services. These new devices, along with the Invia ... to provide innovative, high-quality NPWT solutions, designed to ... patients. "We are happy to be ...
Breaking Medicine Technology:Pemphigus Therapeutic Development and Pipeline Review H1 2015 2Pemphigus Therapeutic Development and Pipeline Review H1 2015 3Pemphigus Therapeutic Development and Pipeline Review H1 2015 4SCILEX Pharmaceuticals Announces Strategic Investment By ITOCHU CHEMICAL FRONTIER Corporation 2Medela Launches Product Line to Support Individualized Care For Negative Pressure Wound Therapy Patients 2
Cached News: